Ornidazole
Trials 48 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials | ||||||
| Phase 0 | NCT07683936 | Jun 2026 → Jan 2027 expected | hepatic encephalopathy | Air Force Military Medical University, China | Recruiting | No outcome recorded |
| Phase 0 | NCT07003438 | Jun 2025 → Apr 2026 overdue | steroid-resistant nephrotic syndrome | Zhang Ting | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT05598112 | Apr 2023 → Dec 2026 expected | — | Chinese Academy of Medical Sciences, Fuwai Hospital | Recruiting | No outcome recorded |
| Phase 0 | NCT04975217 | Dec 2021 → Dec 2026 | pancreatic ductal adenocarcinoma | M.D. Anderson Cancer Center | Suspended | No outcome recorded |
| Phase 0 | NCT02733744 | May → Dec 2016 | — | Massachusetts General Hospital | Completed | No outcome recorded |
| Phase 18 trials | ||||||
| Phase 1 | NCT05067595 | Jan 2025 → Dec 2027 expected | graft versus host disease | Fred Hutchinson Cancer Center | Recruiting | No outcome recorded |
| Phase 1 | NCT05911997 | Jan 2024 → Jul 2026 overdue | Clostridium difficile colitis | Icahn School of Medicine at Mount Sinai | Recruiting | No outcome recorded |
| Phase 1 | NCT06030752 | Sep 2023 → Apr 2027 expected | autism spectrum disorder | The Second Hospital of Nanjing Medical University | Recruiting | No outcome recorded |
| Phase 1 | NCT03747718 | Dec 2022 → Dec 2024 | Crohn disease | Stanford University | Withdrawn | No outcome recorded |
| Phase 1 | NCT06368895 | Apr 2021 → Jun 2025 | hepatic encephalopathy, immune dysregulation, neurodevelopmental defects, and colitis | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Unknown | No outcome recorded |
| Phase 1 | NCT03087097 | Apr 2019 → Jul 2020 | protein-energy malnutrition | Microbiome Health Research Institute | Terminated | No outcome recorded |
| Phase 1 | NCT02469272 | May 2015 → Jun 2018 | NAFLD1 | Lifespan | Unknown | No outcome recorded |
| Phase 1 | NCT02399618 | Mar 2015 → Sep 2016 | Clostridium infectious disease | Jinling Hospital, China | Unknown | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT07628777 | Jun 2026 → Mar 2027 expected | heart failure | The First Affiliated Hospital of Air Force Medicial University | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT07454408 | Mar 2026 → Jun 2028 expected | hepatic encephalopathy | Air Force Military Medical University, China | Not yet recruiting | No outcome recorded |
| Phase 1/2 | NCT03167398 | Feb 2018 → Dec 2019 | — | Rambam Health Care Campus | Completed | No outcome recorded |
| Phase 26 trials | ||||||
| Phase 2 | NCT07477782 | May 2026 → Apr 2029 expected | inflammatory bowel disease, primary sclerosing cholangitis | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06218602 | Feb 2024 → Aug 2026 overdue | lymphoma | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04059757 | May 2022 → Jun 2023 | acute graft versus host disease | Leland Metheny | Withdrawn | No outcome recorded |
| Phase 2 | NCT04760665 | Oct 2021 → Nov 2023 | — | Maimónides Biomedical Research Institute of Córdoba | Terminated | No outcome recorded |
| Phase 2 | NCT03998488 | Jan 2020 → Jun 2023 | ulcerative colitis | Weill Medical College of Cornell University | Completed | No outcome recorded |
| Phase 2 | NCT02328547 | May 2015 → Oct 2017 | irritable bowel syndrome | Montefiore Medical Center | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT06603883 | Oct 2024 → Mar 2026 | intestinal dysmotility syndrome | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Completed | No outcome recorded |
| Phase 39 trials | ||||||
| Phase 3 | NCT07458984 | Apr 2026 → Dec 2029 expected | Clostridium difficile colitis | Helsinki University Central Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT06433180 | Jul 2025 → Jul 2028 expected | irritable bowel syndrome | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05266807 | Mar 2023 → Apr 2027 expected | Clostridium difficile colitis | Benoit Guery | Recruiting | No outcome recorded |
| Phase 3 | NCT02801656 | Dec 2020 → Sep 2022 | Clostridium difficile colitis | Memorial University of Newfoundland | Withdrawn | No outcome recorded |
| Phase 3 | NCT03483246 | Sep 2018 → Sep 2025 overdue | ulcerative colitis | Assistance Publique - Hôpitaux de Paris | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03491540 | Sep 2018 → Oct 2023 | rectal cancer | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT03475680 | Aug 2018 → Aug 2021 | colon carcinoma | Assistance Publique - Hôpitaux de Paris | Terminated | No outcome recorded |
| Phase 3 | NCT03819803 | Mar 2017 → Mar 2026 overdue | acute graft versus host disease | Medical University of Graz | Recruiting | No outcome recorded |
| Phase 3 | NCT02618720 | May 2016 → Nov 2019 | — | University Hospital, Clermont-Ferrand | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02998112 | Dec 2016 → Jul 2017 | ulcerative colitis | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
| Phase not applicable15 trials | ||||||
| — | NCT07599046 | Apr 2026 → Jan 2027 expected | type 2 diabetes mellitus | Eighth Affiliated Hospital, Sun Yat-sen University | Not yet recruiting | No outcome recorded |
| — | NCT07464392 | Apr 2026 → Jul 2027 expected | acute pancreatitis | Changhai Hospital | Recruiting | No outcome recorded |
| — | NCT06388863 | Feb 2025 → Dec 2026 expected | Parkinson disease | Shanghai Zhongshan Hospital | Recruiting | No outcome recorded |
| — | NCT06475430 | Jan 2025 → Jun 2026 overdue | — | Peking University People's Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06372184 | Jun 2024 → Jun 2029 expected | allergic rhinitis | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06437041 | Jun 2024 → Dec 2029 expected | irritable bowel syndrome | Faming Zhang | Not yet recruiting | No outcome recorded |
| — | NCT06427863 | Jun 2024 → Dec 2029 expected | constipation disorder | Faming Zhang | Not yet recruiting | No outcome recorded |
| — | NCT06350448 | May 2024 → May 2029 expected | rhinitis | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06333405 | May 2024 → Jan 2025 | necrotizing enterocolitis | Medical University of Warsaw | Unknown | No outcome recorded |
| — | NCT05850572 | Jul 2023 → Dec 2025 overdue | depressive disorder | First Affiliated Hospital Xi'an Jiaotong University | Not yet recruiting | No outcome recorded |
| — | NCT05850585 | Jul 2023 → Dec 2025 overdue | schizophrenia | First Affiliated Hospital Xi'an Jiaotong University | Not yet recruiting | No outcome recorded |
| — | NCT05838118 | Apr 2023 → Dec 2024 | chronic kidney disease | The Second Hospital of Nanjing Medical University | Unknown | No outcome recorded |
| — | NCT05427331 | Jun 2022 → May 2023 | insomnia | Third Military Medical University | Unknown | No outcome recorded |
| — | NCT04861649 | Mar 2021 → Jun 2023 | — | Shanghai Asclepius Meditec Inc. | Unknown | No outcome recorded |
| — | NCT03058900 | May 2017 → Jun 2020 | psoriatic arthritis | Odense University Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 9 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04968951 Comparator | Nov 2021 → Aug 2022 | ulcerative colitis | Ari M Grinspan | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02741518 Comparator | Apr 2017 → Oct 2018 | obesity disorder | Brigham and Women's Hospital | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT05204641 Comparator | Jan 2022 → Oct 2024 | Parkinson disease | Medical University of Warsaw | Completed | No outcome recorded |
| Phase 2 | NCT02346669 Comparator | Apr 2016 → Jan 2018 | obesity disorder, type 2 diabetes mellitus | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT02557685 Comparator | Jun 2015 → Mar 2016 | Clostridium difficile colitis | The Miriam Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT01703494 Comparator | Oct 2012 → May 2015 | Clostridium difficile colitis | Colleen Kelly | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06828874 Comparator | May 2023 → Sep 2024 | infectious peritonitis | Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06744751 Comparator | Sep 2025 → Dec 2026 expected | anorexia nervosa | Shanghai Mental Health Center | Not yet recruiting | No outcome recorded |
| — | NCT03766321 Comparator | Jul 2020 → Oct 2024 overdue | amyotrophic lateral sclerosis | University Hospital of Modena | Active not recruiting | No outcome recorded |
Evidence & citations 16 cited values
Every value below carries the sentence it was read from. 61 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ornidazole | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02618720 ↗ |
| Known as | faecal microbiota transplantation | “Faecal microbiota transplantation (FMT) could be an effective and safe strategy to decolonise intestinal carriers of KPC-producing Klebsiella pneumoniae (KPC-Kp)” PMID 35387830 ↗ Apr 2022 |
| Known as | Fecal Microbiota Transplantation | “Effect of Fecal Microbiota Transplantation on Aging and the Underlying Mechanism of Gut Microbiome Restoration: a Randomized Clinical Trial” NCT05598112 ↗45“Participants will be treated with healthy donor-derived fecal microbiota transplantation in the form of oral capsules.” NCT06388863 ↗ “Objective: To investigate whether Fecal Microbiota Transplantation(FMT) can improve sleep in patients with insomnia” NCT05427331 ↗ |
| Known as | FMT | “A randomised, placebo-controlled trial of faecal microbiota transplantation (FMT) infused into the small intestine of patients with PsA with active peripheral disease who are...” PMID 29703851 ↗ Apr 201821“The process of fecal microbiota transplantation FMT, where fecal microbial community from a healthy individual is transferred into a recipient, has been established as an...” NCT03747718 ↗ “Fecal microbiota transplantation (FMT) is a novel, safe, convenient therapeutic treatment which transplant gut microbiota from donor to patient to rebuild a gut microecology.” NCT05838118 ↗ “Fecal microbiota transplantation (FMT), given as oral capsules, compared with placebo for the treatment of refractory diarrhea-predominant irritable bowel syndrome (IBS-D)” NCT02328547 ↗ “Fecal Microbiota Transplantation (FMT) is the transfer of fecal material from a healthy donor to a patient in order to restore the diversity of the intestinal microbiota.” NCT04059757 ↗ “Fecal microbiota transplant (FMT) is an effective therapy for recurrent Clostridioides difficile infection (rCDI) but has undefined composition and poor scalability.” PMID 42230754 ↗ Jun 2026 “Fecal microbiota transplantation (FMT), in which fecal material enriched with commensal microorganisms is transferred from a healthy donor” NCT03167398 ↗ “The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatment” NCT05266807 ↗ “Objective: To investigate whether Fecal Microbiota Transplantation(FMT) can improve sleep in patients with insomnia” NCT05427331 ↗ “Fecal Microbiota Transplantation (FMT) involves transplanting healthy intestinal flora into a patient's gut.” NCT06744751 ↗ “treatment with fecal microbiota transplantation (FMT) is effective at treating gut-related side effects” NCT06218602 ↗ “fecal microbiota transplantation (FMT) using oral capsules containing frozen stools” NCT06433180 ↗ “Patients will receive four fecal microbiota transplantation (FMT) capsules.” NCT04760665 ↗ “Fecal microbiota transplantation (FMT) by nasal jejunal tube” NCT06603883 ↗ “Fecal Microbiota Transplantation (FMT) Capsules” NCT07628777 ↗ “Fecal Microbiota Transplantation (FMT)” NCT03483246 ↗ “fecal microbiota transplantation (FMT)” NCT02998112 ↗ “Fecal Microbiota Transplantation (FMT)” NCT02733744 ↗ “Fecal microbiota transplantation (FMT)” NCT07599046 ↗ “Fecal microbiota transplantation (FMT)” NCT07477782 ↗ “Fecal microbiota transplantation(FMT)” NCT05850585 ↗ “Fecal microbiota transplantation(FMT)” NCT05850572 ↗ |
| Known as | FMT, stool transplant | “FMT, stool transplant” NCT02557685 ↗ |
| Known as | Healthy donor stool | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07458984 ↗ |
| Known as | Mbiotix | “The patients were randomly assigned to receive either fecal microbiota (Mbiotix, Human Biome Institute) or placebo (auto-fecal microbiota, prepared from the patient's stool) in...” PMID 41674471 ↗ Feb 2026 |
| Known as | MBiotix HBI | “Fecal Microbiota as a suspension obtained from healthy unrelated donor (woman in 3rd trimester of pregnancy) introduced two times per treatment: * as a deep rectal infusion,...” NCT06333405 ↗ |
| Known as | NSC-95075 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | Ornidazol | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | RO 7-0207 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | Tiberal | ChEMBL registry synonym — accepted as the source's own label CHEMBL1449676 ↗ |
| Known as | Washed Microbiota Transplantation | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06030752 ↗ |
| Action | Restore | “to restore missing components of normal intestinal flora” NCT01703494 ↗ |
| Modality | Other / unclassified | “Fecal microbiota transplant from healthy, unrelated donor via freeze-dried capsule” NCT02399618 ↗ |
| Route | Other | “delivered via colonoscopy” NCT01703494 ↗ |